دورية أكاديمية

Integrative medicine use in patients with cutaneous T-Cell lymphoma: A cross-sectional survey study.

التفاصيل البيبلوغرافية
العنوان: Integrative medicine use in patients with cutaneous T-Cell lymphoma: A cross-sectional survey study.
المؤلفون: Mahurin HM; University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA, 98195, United States. Electronic address: mahurinh@uw.edu., Tarabadkar E; Department of Dermatology, Emory University, 1525 Clifton Rd, Atlanta, GA, 30322, United States., Hippe DS; Department of Radiology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, United States., Lachance K; Division of Dermatology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, United States., Kim EJ; Department of Dermatology, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, 19104, United States., Loggers ET; Division of Oncology, University of Washington, 825 Eastlake Ave E, Seattle, WA, 98109, United States; Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, United States., Shinohara MM; Division of Dermatology, University of Washington, 1959 NE Pacific St, Seattle, WA, 98195, United States.
المصدر: Complementary therapies in medicine [Complement Ther Med] 2021 Sep; Vol. 61, pp. 102762. Date of Electronic Publication: 2021 Jul 21.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Scotland NLM ID: 9308777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6963 (Electronic) Linking ISSN: 09652299 NLM ISO Abbreviation: Complement Ther Med Subsets: MEDLINE
أسماء مطبوعة: Publication: Edinburgh : Elsevier
Original Publication: Edinburgh ; New York : Churchill Livingstone, c1993-
مواضيع طبية MeSH: Integrative Medicine* , Lymphoma, T-Cell, Cutaneous*/therapy , Skin Neoplasms*/therapy, Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Quality of Life
مستخلص: Objectives: To characterize patterns of integrative medicine (IM) use and health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma (CTCL).
Design: Cross-sectional, online survey, created in conjunction with the Cutaneous Lymphoma Foundation (CLF).
Setting: A link to the online survey was posted on the CLF Facebook page and emailed to the CLF listserv; 372 survey responses were received.
Main Outcome Measures: The study outcomes were IM use, cancer symptoms, and HRQoL measured via the Skindex-16 and Functional Assessment of Cancer Therapy-General (FACT-G).
Results: A total of 292 patient responses (66 % female, median age 59y) were included in analysis. 87 % had mycosis fungoides and 12 % had Sézary syndrome. A majority (59 %) of patients reported using IM for their CTCL, with 48 % using IM to treat their disease and 47 % using IM to manage their symptoms. The most commonly used IM were vitamins/minerals (32 %), prayer/meditation (26 %), diet (24 %), and exercise/yoga (22 %). Higher itch scores were reported by patients using IM compared to non-users (31 (IQR 10-62) and 18 (IQR 3-46) respectively; p = 0.002). HRQoL was worse among patients who reported IM use; median Skindex-16 scores were 54 (IQR 28-72) among IM users compared to 33 (IQR 19-57) for non-IM users (p < 0.001).
Conclusions: IM use is common among patients with CTCL, particularly those with worse itching and worse HRQoL. IM interventions require further study given use by CTCL patients to treat disease and ameliorate symptoms.
(Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
فهرسة مساهمة: Keywords: Alternative medicine/complementary medicine; CTCL; Cutaneous lymphoma; Integrative medicine; Itch; Quality of life
تواريخ الأحداث: Date Created: 20210724 Date Completed: 20211124 Latest Revision: 20211124
رمز التحديث: 20240829
DOI: 10.1016/j.ctim.2021.102762
PMID: 34302983
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-6963
DOI:10.1016/j.ctim.2021.102762